Paul Thomas Pugh

Title: Paul Thomas Pugh: Innovator in Ectoparasiticidal Formulations

Introduction

Paul Thomas Pugh is an accomplished inventor based in Knightstown, Indiana. He has made significant contributions to the field of ectoparasiticidal formulations, focusing on innovative solutions for controlling ectoparasite infestations in animals. His work is particularly relevant in veterinary medicine, where effective treatments are essential for animal health.

Latest Patents

One of Paul Thomas Pugh's notable patents is titled "Topical Organic Ectoparasiticidal Formulations." This invention provides topical ectoparasiticidal formulations that comprise an ectoparasiticide, preferably a pyrethroid or a spinosyn. The formulation includes a spreading agent that is a (C-C) branched alkyl (C-C) alkanoate, preferably isopropyl myristate. Additionally, it may contain a miscibilizing agent compatible with organic solvent systems. The methods outlined in this patent are designed to control ectoparasite infestations on certain animals by topically applying such formulations.

Career Highlights

Paul Thomas Pugh is associated with Eli Lilly and Company, a leading pharmaceutical company known for its commitment to innovation and research. His work at Eli Lilly has allowed him to contribute to advancements in veterinary medicine and animal health.

Collaborations

Throughout his career, Paul has collaborated with notable colleagues, including James W. Kassebaum and William Webster Thompson. These collaborations have fostered a productive environment for innovation and development in ectoparasiticidal solutions.

Conclusion

Paul Thomas Pugh's contributions to ectoparasiticidal formulations highlight his dedication to improving animal health through innovative solutions. His patent and work at Eli Lilly and Company reflect his commitment to advancing veterinary medicine.